Kimia Farma participated in the Congress of the Asian Federation of Plastic, Reconstructive, and Aesthetic Surgery Societies (APRAS 2026) and the 29th Annual Scientific Meeting of the Indonesian Association of Plastic, Reconstructive, and Aesthetic Surgeons (InaPRAS 2026) in Bali from September 2 to 5, 2026.
At this forum, which brought together experts and practitioners in plastic, reconstructive, and aesthetic surgery, Kimia Farma introduced StemXera—a regenerative medicine innovation comprising stem cells and secretomes developed in collaboration with Dr. Cipto Mangunkusumo National Central General Hospital (RSUPN) and the Faculty of Medicine, Universitas Indonesia (FKUI).
This participation reflects Kimia Farma’s commitment—as a cornerstone of national health resilience—to delivering sustainable, science-based innovations and biotechnology, while also fostering opportunities for collaboration and knowledge exchange to advance regenerative medicine services in Indonesia.